Literature DB >> 25755520

A review and current perspective on Wilson disease.

Mallikarjun Patil1, Keyur A Sheth1, Adarsh C Krishnamurthy1, Harshad Devarbhavi1.   

Abstract

Wilson disease is a rare, inherited autosomal recessive disease of copper metabolism and may be more common where consanguinity is prevalent. Much has been known about the disease after it was first described by Kinnier Wilson as 'progressive lenticular degeneration in 1912. Over 500 mutations of the ATP7B gene has been identified with no clear genotype to phenotype correlation. Loss of ATP7B function leads various grades of reduced biliary excretion of copper and reduced incorporation of copper into ceruloplasmin; accumulation and toxicity of copper in the liver, brain and other tissues results in liver toxicity and other myriad manifestations of the disease. The clinical features may vary from asymptomatic state to chronic liver disease, acute liver failure, neuropsychiatric manifestations and hemolytic anemia. Diagnosis is based on the combination of clinical sign's, biochemical features, histologic findings and mutation analysis of ATP7B gene. Subtle geographical differences exist with a disproportionate proportion of children presenting with acute liver failure. A high index of suspicion is needed for an early diagnosis. Ratios of biochemical indices for early diagnosis need validation across geographical regions and may not be particularly applicable in children. Better biomarkers or the need for tests for early detection of ALF persists. Drugs used in the treatment of Wilson disease include copper chelating agents such as d-Penicillamine, trientine and zinc salt. Untreated Wilson disease uniformly leads to death from liver disease or severe neurological disability. Early recognition and treatment has excellent prognosis. Liver transplantation is indicated in acute liver failure and end stage liver disease. Family screening in order to detect the disorder in the first-degree relatives is warranted. This review provides an overview of different aspects of Wilson disease including geographical differences in presentations and clinical management and the limitations of currently available tests.

Entities:  

Keywords:  ALF, acute liver failure; ATP7B; CCS1, copper chaperone for superoxide dismutase 1; CT, computerized tomography; CTR-1, copper transporter protein; MRI, magnetic resonance imaging; OLT, orthotropic liver transplantation; SOD1, superoxide dismutase; TM, tetrathiomolybdate; UNOS, United network for organ sharing; XIAP, X linked inhibitor of apoptosis; ceruloplasmin; chelators; liver failure; mutation

Year:  2013        PMID: 25755520      PMCID: PMC3940372          DOI: 10.1016/j.jceh.2013.06.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  118 in total

1.  Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson's disease diagnosis.

Authors:  Souleiman El Balkhi; Jean-Marc Trocello; Joël Poupon; Philippe Chappuis; France Massicot; Nadège Girardot-Tinant; France Woimant
Journal:  Clin Chim Acta       Date:  2011-08-22       Impact factor: 3.786

2.  Wilson's disease in children: 37-year experience and revised King's score for liver transplantation.

Authors:  Anil Dhawan; Rachel M Taylor; Paul Cheeseman; Pamela De Silva; Leah Katsiyiannakis; Giorgina Mieli-Vergani
Journal:  Liver Transpl       Date:  2005-04       Impact factor: 5.799

3.  Chelation treatment of neurological Wilson's disease.

Authors:  J M Walshe; M Yealland
Journal:  Q J Med       Date:  1993-03

4.  Collagen cross-linking. Effect of D-penicillamine on cross-linking in vitro.

Authors:  R C Siegel
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

5.  Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.

Authors:  J M Walshe
Journal:  Q J Med       Date:  1989-03

6.  Wilson's disease: clinical presentation and use of prognostic index.

Authors:  H Nazer; R J Ede; A P Mowat; R Williams
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

7.  The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1).

Authors:  J M Walshe
Journal:  Prog Clin Biol Res       Date:  1979

8.  Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509.

Authors:  Alastair Compston
Journal:  Brain       Date:  2009-08       Impact factor: 13.501

9.  Juvenile Wilson disease: histologic and functional studies during penicillamine therapy.

Authors:  R J Grand; G F Vawter
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

Review 10.  The metabolism and pharmacology of D-penicillamine in man.

Authors:  D Perrett
Journal:  J Rheumatol Suppl       Date:  1981 Jan-Feb
View more
  24 in total

1.  Hepatobiliary quiz-9 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-03

Review 2.  Insights into the management of Wilson's disease.

Authors:  Mohmadshakil Kathawala; Gideon M Hirschfield
Journal:  Therap Adv Gastroenterol       Date:  2017-10-03       Impact factor: 4.409

3.  Neurological features and management of Wilson disease in children: an evaluation of 12 cases.

Authors:  Ayşe Kaçar Bayram; Hakan Gümüş; Duran Arslan; Güldemet Kaya Özçora; Sefer Kumandaş; Neslihan Karacabey; Mehmet Canpolat; Hüseyin Per
Journal:  Turk Pediatri Ars       Date:  2016-03-01

4.  Case 1: A 12-year-old boy with acute liver failure.

Authors:  Dustin Jacobson; Holden Sheffield; Simon Ling
Journal:  Paediatr Child Health       Date:  2016-04       Impact factor: 2.253

5.  Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam.

Authors:  Nguyen Thi Mai Huong; Nguyen Pham Anh Hoa; Ngo Diem Ngoc; Nguyen Thi Phuong Mai; Pham Hai Yen; Hoàng Thị Vân Anh; Giang Hoa; Tran Minh Dien
Journal:  Mol Genet Metab Rep       Date:  2022-03-15

Review 6.  Contribution of metals to brain MR signal intensity: review articles.

Authors:  Tomonori Kanda; Yudai Nakai; Shuri Aoki; Hiroshi Oba; Keiko Toyoda; Kazuhiro Kitajima; Shigeru Furui
Journal:  Jpn J Radiol       Date:  2016-03-01       Impact factor: 2.374

7.  Wilson disease with hepatic presentation in an eight-month-old boy.

Authors:  Kuerbanjiang Abuduxikuer; Li-Ting Li; Yi-Ling Qiu; Neng-Li Wang; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

8.  A caged imidazopyrazinone for selective bioluminescence detection of labile extracellular copper(ii).

Authors:  Justin J O'Sullivan; Valentina Medici; Marie C Heffern
Journal:  Chem Sci       Date:  2022-03-23       Impact factor: 9.825

9.  Development of low-density oligonucleotide microarrays for detecting mutations causing Wilson's disease.

Authors:  Manjula Mathur; Ekta Singh; T B Poduval; Akkipeddi V S S N Rao
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

10.  Analysis of penicillamine using Cu-modified graphene quantum dots synthesized from uric acid as single precursor.

Authors:  Gema M Durán; Tomás E Benavidez; Ana M Contento; Angel Ríos; Carlos D García
Journal:  J Pharm Anal       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.